Showing results (391-400 of 461) with videos related to

Sort By:
Pageof 47
Mayo Clinic Proceedings|December 4, 2009
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelinesShaji K Kumar, Joseph R Mikhael, Francis K Buadi, et al.
Transplantation and Cellular Therapy|April 26, 2025
Coronary Artery Calcification as a Predictor of Survival in Patients Receiving Post-transplant Cyclophosphamide for GVHD ProphylaxisChristopher Graham, Anmol Baranwal, Bas Kietselaer, et al.
Blood Cancer Journal|March 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapyJoselle Cook, Supriya Gupta, Nadine Abdallah, et al.
American Journal of Hematology|August 9, 2016
Outcomes of patients with renal monoclonal immunoglobulin deposition diseaseTaxiarchis V Kourelis, Samih H Nasr, Angela Dispenzieri, et al.
American Journal of Hematology|October 26, 2017
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myelomaArjun Lakshman, Preet Paul Singh, S Vincent Rajkumar, et al.
American Journal of Hematology|January 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantationNadine H Abdallah, Thomas Habermann, Francis K Buadi, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2021
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care CenterLaura A Evans, Ronald Go, Rahma Warsame, et al.
Bone Marrow Transplantation|December 23, 2017
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosisSurbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Blood Advances|November 23, 2018
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myelomaMohammed A Aljama, M Hasib Sidiqi, Arjun Lakshman, et al.
British Journal of Haematology|July 13, 2019
Ten-year survivors in AL amyloidosis: characteristics and treatment patternEli Muchtar, Morie A Gertz, Martha Q Lacy, et al.
Pageof 47